FDA advisory panel backs approval of neoadjuvant pertuzumab for breast cancer http://bit.ly/163qi4Y
5:33 PM - 13 Sep 2013
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.